Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually) Editorial
| Authors: | Czernin, J.; Bodei, L.; Modlin, I.; Calais, J. |
| Title: | Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually) |
| Keywords: | cancer chemotherapy; treatment response; overall survival; nonhuman; clinical practice; medical decision making; progression free survival; editorial; prediction; neuroendocrine tumor; prostate cancer; diagnosis; radiopharmaceutical agent; octreotide; therapy; somatostatin receptor; cabazitaxel; human; article; peptide receptor radionuclide therapy; aversion; vipivotide tetraxetan lutetium lu 177; lutetium dotatate lu 177 |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 66 |
| Issue: | 3 |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2025-03-01 |
| Start Page: | 333 |
| End Page: | 336 |
| Language: | English |
| DOI: | 10.2967/jnumed.124.269401 |
| PUBMED: | 39915128 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
